Acute presentations of lung cancer. Dr Prina Ruparelia Respiratory consultant Cambridge University Hospital

Size: px
Start display at page:

Download "Acute presentations of lung cancer. Dr Prina Ruparelia Respiratory consultant Cambridge University Hospital"

Transcription

1 Acute presentations of lung cancer Dr Prina Ruparelia Respiratory consultant Cambridge University Hospital

2 The problem Incidence CADIAS report /NCIN Acute lung cancer presentations Future pathway developments

3 CRUK Incidence of lung cancer

4 Emergency presentations of cancer ncin.org.uk

5 Survival according to presentation BJC 2012: ncin.org.uk

6 Cancer Diagnosis in an Acute Setting (CADIAS) Barriers to seeking medical attention Patient perceived factors (66%) GP access factors- 25%

7 Local effects Lung Metastatic lesions- cardiac, neurological, bone Endocrine effects Paraneoplastic effects

8 Infection Local effects of occlusion for example pneumonia more common in patients with an occluded airway

9 Case 1 81 year old lady Ex-smoker History of memory impairment 3 week history of dyspnoea Persistent cough. New diagnosis of paroxysmal AF On examination Oxygen sats 92% on air. Noted to have an inspiratory wheeze in the left upper lobe

10 Presentation CXR Chest radiograph 2011

11

12 Measures to improve airway patency Chest clearance techniques Physiotherapy cautiously Saline nebulisers Steroid treatment Visualisation by bronchoscopy to assess suitable interventions Interventional techniques Bronchoscopy with cryotherapy Stenting

13

14 Improving airway patency Is an effective palliative measure May prolong survival and improve performance status such that the individual may be able to undergo chemotherapy Consider whether the airway may be at risk prior to discharging the patient, particular consideration of the main bronchi and proximity to the carina Be aware of your local arrangements- Interventional pulmonology, thoracic surgeons

15 Measures to improve airway patency Cryotherapy Argon Laser Stenting Combination of above

16 Case Report 2 65 year old lady never smoker Presented with pleuritic chest pain Shortness of breath

17 Predisposition thromboembolic disease Hypercoagulable state Clinical thromboembolism occurs in up to 11% of patients with malignancy Certain malignancies may have higher predisposition for example pancreatic cancer Other common cancers associated with PE are GI malignancies, lung cancer

18 Thromboembolic disease Several investigators have attempted to define risk factors to identify the subset of patients likely to benefit from extensive screening for malignancy. In one study, cancer was diagnosed in 16 of 136 patients (12 percent) with idiopathic DVT during the index hospitalization 1. All 16 had one or more abnormalities suggestive of possible malignancy on at least one of the four components of the initial investigation: history, physical examination, basic laboratory testing, or chest X-ray. In a second series, 13 new malignancies were diagnosed among 326 patients with DVT during a 6-month follow-up period 2. Ten of the 13 had some type of clinical abnormality at presentation, and 7 were diagnosed within the first 16 days based upon patient characteristics and clinical findings on initial routine examination and laboratory testing. 1. Cornuz J et al Ann Intern Med ;125(10): Hettiarachchi RJ et al Cancer Jul 1;83(1):180-5.

19 Treatment- VTE There is both a risk and benefit in the treatment of patients with the malignant disease Retrospective analysis in 1303 patients with thromboembolic disease ( 264 patients in this group had underlying malignancy) Overall incidence of recurrent VTE in those with malignancy is 3.5 times higher 6.5 times higher risk of bleeding

20 Van Doormal et al % of patients in extensive screening identified as having cancer ( CT abdo, chest and mammogram) 2.4% of patients in limited screening identified as having cancer (history, physical examination, basic lab test and CXR) Of those identified 8.3% died in extensive screening group versus 7.6% of limited screening group Thromb Haemost Jan;9(1):79-84

21 Investigation for underlying malignancy Ensure people with unprovoked pulmonary embolism(pe) are investigated for the possibility of an undiagnosed cancer if they are not already known to have cancer. Initially undertake: A full history and physical examination to look for evidence of malignancy. A chest X-ray. Blood tests including a full blood count, serum calcium, and liver function tests. Urinalysis. Consider referral for further investigations for cancer with an abdomino-pelvic CT scan (and mammogram in women) in all people over 40 years with a first unprovoked PE who do not have features of cancer based on the initial investigations above. In people with an unprovoked PE, consider antiphospholipid testing (anticardiolipin or anti-beta glycoprotein I antibodies) before stopping anticoagulants. In people with an unprovoked PE who have a first-degree relative who has had a DVT or PE, consider arranging hereditary thrombophilia testing (antithrombin, protein C, and protein S testing).

22 84 year old lady ex teacher Progressive dyspnoea Swelling anterior chest wall CT guided biopsy of left chest wall mass Histology: Mesothelioma Recurrent pleural aspirations Indwelling drain placed Case 3

23 Lungs and cancer Pleural effusions - Pleural aspiration - Medical pleurodesis - VATS pleurodesis - Indwelling pleural drain

24 Indwelling drains

25 Case 4 Mrs SS 74 year old lady recently retired 3 week history of increasing dyspnoea Ex-smoker PS 0

26

27 Management Pericardial aspiration ( therapeutic and diagnostic) Pericardiostomy ( pericardial window) Pericardial stripping Treat the malignancy

28 Pressure on local structures E.g. SVC obstruction

29

30

31 Further management SVC stent insertion Urgent need for biopsy High dose steroid treatment- consider timing Radiotherapy

32 Bony involvement Pain from metastatic lesions Pathological fractures Spinal cord compression

33 Case 5- bony lesions 91 year old gentleman Presented following a fall Acute right hip pain on a background of chronic hip pain

34 MRI hip

35 Considerations Pain relief including bisphosphonates Hip involvement consider benefits from hip stabilisation Consider radiotherapy for refractory pain This patient had resolution of hip pain following surgery but then later had recurrence of pain for which he required radiotherapy

36 Case 5: spinal cord compression 63 year old current smoker Presented with a 5 week history of back pain radiating to the groin Leg weakness No loss of sphincter control

37 Spinal Instability Neoplasia score Fourney et al: JCO 29, 22;

38 Case 6 Mrs RP 65 year old lady presented with generalised weakness Poor appetite During admission developed progressive neurological weakness Differential diagnosis myasthenia gravis, motor neurone disease, paraneoplastic disease Developed progressive respiratory failure EMG inconclusive CT chest mass

39 Imaging

40 Paraneoplastic conditions Paraneoplastic neurologic syndromes are a heterogeneous group of disorders caused by mechanisms other than metastases, metabolic and nutritional deficits, infections, coagulopathy or side effects of cancer treatment. These syndromes may affect any part of the nervous system from cerebral cortex to neuromuscular junction and muscle

41

42 Paraneoplastic syndromes P/Q type voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome (LEMS) Acetylcholine receptor antibodies in myasthenia gravis NMDA receptor (NR1) antibodies in anti-nmdar encephalitis AMPA receptor (GluR1/2) antibodies in a subgroup of limbic encephalitis Ganglionic acetylcholine receptor antibodies in autonomic neuropathy Recoverin antibodies in carcinoma associated retinopathy

43 Endocrine disturbance Hyponatremia Medication SIADH Hypoadrenal due to adrenal metastates Hypercalcaemia Bone mets PTH related peptide Hyperkalaemia Medication ACTH producing tumour

44 Case 7 82 year old lady Previously fit and well Admitted with acute confusional state Na 110 Confirmed SIADH Na increased to 132 with fluid restriction

45 Skin and Cancer- Case 8 74 year old lady presented with increased shortness of breath Had also noted 2 week history of rash on the back of hands On closer questioning mentioned difficulty climbing the stairs Had proximal muscle weakness

46 Case 9 54 year old nurse Referred to the rheumatology department with bilateral wrist and ankle swelling and joint pains CXR abnormal Hypertrophic Pulmonary Osteoarthropathy

47 Case year old lady Admitted following a first seizure which resulted in RTA Patient also has a solitary lung lesion Consider possibility of surgery in the instance of oligometastases.

48 Proposal Timed pathway for patients with suspected lung cancer admitted as an emergency Seeing a member of acute oncology service/ lung team within 24 hours CT within 48 hours Review by the lung MDT within a week Seen by member of lung MDT within one week

49 Screening using low dose CT NSLT ( US) Nelson UKLS

50 Questions

Lung Cancer - Suspected

Lung Cancer - Suspected Lung Cancer - Suspected Shared Decision Making Lung Cancer: http://www.enhertsccg.nhs.uk/ Patient presents with abnormal CXR Lung cancer - clinical presentation History and Examination Incidental finding

More information

Lung Cancer. Definition of lung cancer Malignancy arising from lung tissue

Lung Cancer. Definition of lung cancer Malignancy arising from lung tissue Lung Cancer Definition of lung cancer Malignancy arising from lung tissue Epidemiology of lung cancer Commonest malignancy in western world Commonest cause of death in men and women in the UK Approximately

More information

Faster Cancer Treatment Indicators: Use cases

Faster Cancer Treatment Indicators: Use cases Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

Oncologic Emergencies

Oncologic Emergencies Oncologic Emergencies Objectives Identify the major oncologic emergencies Describe the assessment for each emergency Outline the standard of care of patients experiencing oncologic emergencies Structural

More information

MSCC CARE PATHWAYS & CASE STUDIES. By Michael Balloch Spine CNS

MSCC CARE PATHWAYS & CASE STUDIES. By Michael Balloch Spine CNS MSCC CARE PATHWAYS & CASE STUDIES By Michael Balloch Spine CNS Aims To be familiar with the routes of MSCC prentaion How the guidelines work in practice Routes of presentation Generic intervention Managing

More information

Lung Cancer Case Study

Lung Cancer Case Study Lung Cancer Case Study Presented by s GP Education Programme 2 Part One Initial presentation 60 year old lady, presents with a 6 week history of right sided chest pain. The pain is like a dull ache, but

More information

Adam J. Hansen, MD UHC Thoracic Surgery

Adam J. Hansen, MD UHC Thoracic Surgery Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered

More information

Bronchogenic Carcinoma

Bronchogenic Carcinoma A 55-year-old construction worker has smoked 2 packs of ciggarettes daily for the past 25 years. He notes swelling in his upper extremity & face, along with dilated veins in this region. What is the most

More information

NICE Quality Standards and COF

NICE Quality Standards and COF NICE Quality Standards and COF David Baldwin Consultant Respiratory Physician NUH Hon Senior Lecturer Nottingham University Clinical lead NICE lung cancer GL Chair NICE QS Topic Expert Group Quality Standards

More information

Oncologic Emergencies: When to call the Radiation Oncologist

Oncologic Emergencies: When to call the Radiation Oncologist Oncologic Emergencies: When to call the Radiation Oncologist Dr. Shrinivas Rathod Radiation Oncologist Radiation Oncology Program CancerCare Manitoba and University of Manitoba Disclosures Speaker s name:

More information

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease Refer back to original requester with this paperwork and review previous

More information

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V3 MSCC Network

More information

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality

More information

Lung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo

Lung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo Lung Cancer-a primer Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo CLINICAL CATEGORIES THE SOLITARY PULMONARY NODULE MULTIPLE PULMONARY NODULES Differential Diagnosis Malignant

More information

Pulmonary Embolism Pathway

Pulmonary Embolism Pathway Pulmonary Embolism Pathway Ambulatory Care Pathway Dr. A. Zafar, Dr. A. Rehman, Dr. T. Malik September, 2011. Patient Identification Label Pulmonary Embolism Pathway Clinical History Comments Hospital

More information

THORACIK RICK. Lungs. Outline and objectives Richard A. Malthaner MD MSc FRCSC FACS

THORACIK RICK. Lungs. Outline and objectives Richard A. Malthaner MD MSc FRCSC FACS THORACIK RICK Outline and objectives Lungs Management of a solitary lung nodule Mediastinum Management of a mediastinal mass Pleura Management of a pleural fluid & pneumothorax Esophagus & Stomach Management

More information

Definition. Epidemiology. Lung Cancer is a disease which cancer (malignant tumors) cells grow in the lungs. LUNG CANCER Debra Mercer BSN, RN, RRT

Definition. Epidemiology. Lung Cancer is a disease which cancer (malignant tumors) cells grow in the lungs. LUNG CANCER Debra Mercer BSN, RN, RRT LUNG CANCER Debra Mercer BSN, RN, RRT Definition Lung Cancer is a disease which cancer (malignant tumors) cells grow in the lungs. Epidemiology Leading cancer killer in both men and women in the US - 169,

More information

PROGNOSIS AND SURVIVAL

PROGNOSIS AND SURVIVAL CANCER ASSOCIATED THROMBOSIS PROGNOSIS AND SURVIVAL Since French internist Armand Trousseau reported the occurrence of mysterious thrombotic disorders in cancer patients in the mid-19th century, the link

More information

ISPUB.COM. Rare Cases: Tracheal/bronchial Obstruction. O Wenker, L Moehn, C Portera, G Walsh HISTORY ADMISSION

ISPUB.COM. Rare Cases: Tracheal/bronchial Obstruction. O Wenker, L Moehn, C Portera, G Walsh HISTORY ADMISSION ISPUB.COM The Internet Journal of Radiology Volume 1 Number 1 O Wenker, L Moehn, C Portera, G Walsh Citation O Wenker, L Moehn, C Portera, G Walsh.. The Internet Journal of Radiology. 1999 Volume 1 Number

More information

Metastatic Spinal Cord Compression

Metastatic Spinal Cord Compression Metastatic Spinal Cord Compression Dr Zacharias Tasigiannopoulos Clinical Oncologist Colney centre Department of Oncology Norwich, UK Introduction 2-5% of cancer patients have an episode of MSCC Initial

More information

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Update on Management of Malignant Spinal Cord Compression Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Current Guidelines The symptoms of MSCC may be subtle and therefore careful

More information

Request Card Task ANSWERS

Request Card Task ANSWERS Request Card Task ANSWERS Medical Student Workbook Author: Dr Sam Leach, SpR Case 1 What differential diagnoses are most likely? Which investigation is most appropriate? Case 1 The most likely diagnosis

More information

Interventional Pulmonary Case Based Discussions (ATS) Ali Imran Saeed, MD University of New Mexico

Interventional Pulmonary Case Based Discussions (ATS) Ali Imran Saeed, MD University of New Mexico Interventional Pulmonary Case Based Discussions (ATS) Ali Imran Saeed, MD University of New Mexico Objectives Interventional Pulmonary in New Mexico Interventional Pulmonary and Advanced Diagnostic Cases

More information

Palliative Care Emergencies

Palliative Care Emergencies Palliative Care Emergencies LAURA BARNFIELD What might constitute an emergency in Palliative Care? 1 Palliative Care Emergencies Major haemorrhage Metastatic Spinal Cord Compression (MSCC) Superior Vena

More information

Sinus and Cerebral Vein Thrombosis

Sinus and Cerebral Vein Thrombosis Sinus and Cerebral Vein Thrombosis A Summary Sinus and cerebral vein clots are uncommon. They can lead to severe headaches, confusion, and stroke-like symptoms. They may lead to bleeding into the surrounding

More information

Oncologic Emergencies

Oncologic Emergencies Oncologic Emergencies Peter Bjerkerot RN, OCN 1339 Normandy Drive Atlanta, GA 30306-2574 404.754.5952 WebPage http://boyrn.com peter.bjerkerot@mindspring.com Full Disclosure Statement Celgene Nurse Advisory

More information

Breathlessness in advanced disease. February 2017

Breathlessness in advanced disease. February 2017 Breathlessness in advanced disease February 2017 Breathlessness Managing breathlessness in primary care Chronic breathlessness Acute exacerbation of breathlessness Breathlessness at end of life Breathlessness

More information

SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary)

SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary) SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Desiree Hao (Staff Medical Oncologist, University of Calgary) and Dr.

More information

Quality Care Innovation lead clinician for integrated respiratory service georges ng* man kwong

Quality Care Innovation lead clinician for integrated respiratory service georges ng* man kwong Working in partnership Quality Care Innovation lead clinician for integrated respiratory service georges ng* man kwong chest physician pronounced ning qualified 1990 chief clinical information officer

More information

Contents. Contributors. Reviewers. Acknowledgements I CARDIOVASCULAR COMPLICATIONS

Contents. Contributors. Reviewers. Acknowledgements I CARDIOVASCULAR COMPLICATIONS Contributors Reviewers Acknowledgements Preface xii xvi xvii xviii I CARDIOVASCULAR COMPLICATIONS 1 Cardiac Complications of Cancer and Anticancer Treatment 3 Introduction 3 Malignant Pericardial Effusion

More information

Understanding surgery

Understanding surgery What does surgery for lung cancer involve? Surgery for lung cancer involves an operation, which aims to remove all the cancer from the lung. Who will carry out my operation? In the UK, we have cardio-thoracic

More information

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical Pulmonary embolus - a practical approach to investigation and treatment Sam Janes Wellcome Senior Fellow and Respiratory Physician, University College London Background Diagnosis Treatment Common: 50 cases

More information

CT PET SCANNING for GIT Malignancies A clinician s perspective

CT PET SCANNING for GIT Malignancies A clinician s perspective CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset

More information

Liver and Pancreatic Case discussion

Liver and Pancreatic Case discussion The Royal Marsden Liver and Pancreatic Case discussion Dr Ian Chau Consultant Medical Oncologist The Royal Marsden 77 year old gentleman with 2 months history of vague abdominal ache and clinically finding

More information

Potpourri of Hematology Oncology. Jasmine Nabi, M.D. Oncology Associates Hall-Perrine Cancer Center at Mercy

Potpourri of Hematology Oncology. Jasmine Nabi, M.D. Oncology Associates Hall-Perrine Cancer Center at Mercy Potpourri of Hematology Oncology Jasmine Nabi, M.D. Oncology Associates Hall-Perrine Cancer Center at Mercy Lifestyle Modifications to Decrease the Risk of Colorectal Cancer Estimates for 2018 American

More information

WHAT IS YOUR DIAGNOSIS?

WHAT IS YOUR DIAGNOSIS? WHAT IS YOUR DIAGNOSIS? An 8 year old, female neutered cross breed dog was presented to the R(D)SVS Internal Medicine Service following a 2 month history of ataxia and collapsing episodes which occurred

More information

North of Scotland Cancer Network Clinical Management Guideline for Mesothelioma

North of Scotland Cancer Network Clinical Management Guideline for Mesothelioma THIS DOCUMENT IS North of Scotland Cancer Network Clinical Management Guideline for Mesothelioma [Based on WOSCAN SCLC CMG with further extensive consultation within NOSCAN] UNCONTROLLED WHEN PRINTED Document

More information

GUIDELINES FOR RADIOTHERAPY IN SPINAL CORD COMPRESSION THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. Version:

GUIDELINES FOR RADIOTHERAPY IN SPINAL CORD COMPRESSION THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. Version: GUIDELINES FOR RADIOTHERAPY IN SPINAL CORD COMPRESSION THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V4 Acute Oncology Group

More information

Appendix to Gibson et al. Application of a decision rule and a D-dimer assay in the

Appendix to Gibson et al. Application of a decision rule and a D-dimer assay in the Appendix to Gibson et al. Application of a decision rule and a D-dimer assay in the diagnosis of pulmonary embolism (Thromb Haemost 2010; 103.4) Case 1 You are paged by an emergency room physician, who

More information

Malignant Effusions. Anantham Devanand Respiratory and Critical Care Medicine Singapore General Hospital

Malignant Effusions. Anantham Devanand Respiratory and Critical Care Medicine Singapore General Hospital Malignant Effusions Anantham Devanand Respiratory and Critical Care Medicine Singapore General Hospital Malignant Effusions Definition: Presence of malignant cells in the pleural space 75% are caused by

More information

THORACIC MALIGNANCIES

THORACIC MALIGNANCIES THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,

More information

Thoracoscopy for Lung Cancer

Thoracoscopy for Lung Cancer Thoracoscopy for Lung Cancer Introduction The occurrence of lung cancer has increased dramatically over the last 50 years. Your doctor may have recommended an operation to remove your lung cancer. The

More information

2018 OCN Keywords January 22, 2018 Subject Area Weight Keywords

2018 OCN Keywords January 22, 2018 Subject Area Weight Keywords Subject Area Weight Keywords Care Continuum 19% Care Continuum Coordination of Care Navigation Psychosocial Symptom Management Health Promotion/Screening and Early Detection Disease Prevention High-Risk

More information

LCA Lung Clinical Forum. 21 st October 2014

LCA Lung Clinical Forum. 21 st October 2014 LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for

More information

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new

More information

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO)

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Original Prepared by NMcL April 2016

More information

Lung Cancer Very common Very lethal Median age of diagnosis i approximately 70 years, but affects all ages In the United States, the highest incidence

Lung Cancer Very common Very lethal Median age of diagnosis i approximately 70 years, but affects all ages In the United States, the highest incidence LUNG CANCER 2010 Mark B. Stoopler, M.D. Division of Medical Oncology Lung Cancer Very common Very lethal Median age of diagnosis i approximately 70 years, but affects all ages In the United States, the

More information

Neurologic Complications of Cancer. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge Ontario

Neurologic Complications of Cancer. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge Ontario Neurologic Complications of Cancer Dr. Kathryn Giles MD, MSc, FRCPC Cambridge Ontario Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Recognition & Treatment of Malignant Spinal Cord Compression Study Day

Recognition & Treatment of Malignant Spinal Cord Compression Study Day Recognition & Treatment of Malignant Spinal Cord Compression Study Day 11 th May 2017 Dr Bernie Foran Consultant Clinical Oncologist & Honorary Senior Lecturer Weston Park Hospital Outline of Talk Clinical

More information

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

Primary care referral criteria for musculoskeletal MRI scans

Primary care referral criteria for musculoskeletal MRI scans Appendix 1 Primary care referral criteria for musculoskeletal MRI scans Accepted Criteria for Direct Access MRI Body Part Symptoms Imaging indicated Lumbar Spine Low Back Pain with adverse symptoms or

More information

3/30/2009 Lung Cancer Deaths 2008 Lung Cancer Deaths Lung Cancer Deaths--Males Males 5

3/30/2009 Lung Cancer Deaths 2008 Lung Cancer Deaths Lung Cancer Deaths--Males Males 5 LUNG CANCER 2009 Mark B. Stoopler, M.D. Division of Medical Oncology Very common Very lethal Lung Cancer Median age of diagnosis approximately 70 years, but affects all ages(even pediatric!) Advances in

More information

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2. Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.

More information

Lung Cancer Incidence 2008 Lung Cancer Deaths-Males 2008 Incidence Total U.S.(all types): 1,437,180 Lung Cancer Deaths-Females Lung cancer 215,000(15%

Lung Cancer Incidence 2008 Lung Cancer Deaths-Males 2008 Incidence Total U.S.(all types): 1,437,180 Lung Cancer Deaths-Females Lung cancer 215,000(15% Multidisciplinary approach 2009 Mark B. Stoopler, M.D. Division of Medical Oncology Neurology Neurosurgery Orthopedic surgery General surgery Vascular surgery Gastroenterology Cardiology Lung Cancer Very

More information

Palliative treatments for lung cancer: What can the oncologist do?

Palliative treatments for lung cancer: What can the oncologist do? Palliative treatments for lung cancer: What can the oncologist do? Neil Bayman Consultant Clinical Oncologist GM Cancer Palliative Care and Lung Cancer Education Event Manchester, 31 st January 2017 Most

More information

Epidermiology Early pulmonary embolism

Epidermiology Early pulmonary embolism Epidermiology Early pulmonary embolism Sitang Nirattisaikul Faculty of Medicine, Prince of Songkla University 3 rd most common cause of cardiovascular death in the United States, following ischemic heart

More information

Pathology of Tumors of Lung Pathology of Tumors of Lung o Classify lung tumors.

Pathology of Tumors of Lung Pathology of Tumors of Lung o Classify lung tumors. Pathology of Tumors of Lung Pathology of Tumors of Lung o Classify lung tumors. o Classify bronchogenic carcinoma. o Discuss etiopathogenesis of bronchogenic ca. o Discuss morphological features of squamous

More information

The management and treatment options for secondary bone disease. Dr Jason Lester Clinical Oncologist Velindre Cancer Centre

The management and treatment options for secondary bone disease. Dr Jason Lester Clinical Oncologist Velindre Cancer Centre The management and treatment options for secondary bone disease Dr Jason Lester Clinical Oncologist Velindre Cancer Centre Aims Overview of bone metastases management in castrate-refractory prostate cancer

More information

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to

More information

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE

More information

Pulmonary Test Brenda Shinar

Pulmonary Test Brenda Shinar Pulmonary Test 2016 Brenda Shinar 1. What is a Renal Tubular Acidosis? What is the difference between the types of RTAs in terms of who gets them and how to diagnose them? Type 1, 2, and 4? Metabolic acidosis

More information

PREAMBLE GENERAL DIAGNOSTIC RADIOLOGY

PREAMBLE GENERAL DIAGNOSTIC RADIOLOGY PREAMBLE The General Diagnostic Radiology category is intended to cover the body of knowledge a practicing board certified Diagnostic Radiologist should know. Since the range of content relevant to the

More information

National Optimal Lung Cancer Pathway

National Optimal Lung Cancer Pathway National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August

More information

The adult with recurrent breathlessness. A/Prof Gerald Chua Medicine NTFGH

The adult with recurrent breathlessness. A/Prof Gerald Chua Medicine NTFGH The adult with recurrent breathlessness A/Prof Gerald Chua Medicine NTFGH Dyspnoea Subjective experience of breathing discomfort Variable among individuals with apparently similar degrees of impairment

More information

Metastatic Spinal Disease

Metastatic Spinal Disease Metastatic Spinal Disease Mr Neil Chiverton Consultant Spinal Surgeon, Sheffield Objectives The scale and nature of the problem NICE recommendations Surgical decision making Case illustrations Incidence

More information

PE service. 65 years old lady. What would you do next? Risk stratification. What would you do next? Regional College Lecture PE Management

PE service. 65 years old lady. What would you do next? Risk stratification. What would you do next? Regional College Lecture PE Management PE service Regional College Lecture PE Management Update in medicine (Eastern) Cambridge 29 th June 2017 Dr Rachel M Limbrey DM FRCP University Hospital Southampton NHS Foundation Trust Ambulatory acute

More information

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

APPROACH TO PLEURAL EFFUSIONS. Raed Alalawi, MD, FCCP

APPROACH TO PLEURAL EFFUSIONS. Raed Alalawi, MD, FCCP APPROACH TO PLEURAL EFFUSIONS Raed Alalawi, MD, FCCP CASE 65-year-old woman with H/O breast cancer presented with a 1 week H/O progressively worsening exersional dyspnea. Physical exam: Diminished breath

More information

BGS Autumn The wet lung - Pleural effusions. Nick Maskell. BGS Autumn Meeting November 2017

BGS Autumn The wet lung - Pleural effusions. Nick Maskell. BGS Autumn Meeting November 2017 The wet lung - Pleural effusions BGS Autumn Meeting November 2017 Nick Maskell Professor of Respiratory Medicine Bristol University, Bristol Conflicts of interest Prof Maskell has sat on advisory boards

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdomen, acute, in oncological surgery patients, critical care issues in, 101 102 Acquired factor VIII inhibitors, in critically ill cancer

More information

Palliative Care Emergencies. Additional module if needed

Palliative Care Emergencies. Additional module if needed Palliative Care Emergencies Additional module if needed Learning objectives Understand emergency /urgent / important Describe common emergencies in PC Explore principles of essential management Outline

More information

Lung Cancer Requirements

Lung Cancer Requirements REFERRAL PROCESS Cancer centres are now participating in the first phase of ereferral, allowing routine medical and radiation oncology referrals for lung cancer to be sent electronically. ereferral functionality

More information

Thoracic Surgery; An Overview

Thoracic Surgery; An Overview Thoracic Surgery What we see Thoracic Surgery; An Overview James P. Locher, Jr, MD Methodist Cardiovascular and Thoracic Surgery Lung cancer Mets Fungus and TB Lung abcess and empyema Pleural based disease

More information

MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION

MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION CLINICAL POLICY MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION DOCUMENT REF: PCLASCORD (Version No. 1.4) Name and designation of policy author(s) Approved by (committee, group, manager)

More information

Canadian Trauma Trials Collaborative. Occult Pneumothorax in Critical Care (OPTICC): Standardized Data Collection Sheet

Canadian Trauma Trials Collaborative. Occult Pneumothorax in Critical Care (OPTICC): Standardized Data Collection Sheet Canadian Trauma Trials Collaborative STUDY CENTRE: Institution: City / Province: / Occult Pneumothorax in Critical Care (OPTICC): Standardized Sheet PATIENT DEMOGRAPHICS: First Name: Health record number

More information

Small Cell Lung Cancer

Small Cell Lung Cancer Small Cell Lung Cancer Small cell lung cancer (SCLC) affects 15% of all lung cancer patients. SCLC is the most aggressive type of lung cancer. It may be treated with chemotherapy and radiation. SCLC has

More information

Dyspnea in the Cancer Patient 33 rd Annual PSONS Nursing Symposium April 1, 2011

Dyspnea in the Cancer Patient 33 rd Annual PSONS Nursing Symposium April 1, 2011 Dyspnea in the Cancer Patient 33 rd Annual PSONS Nursing Symposium April 1, 2011 Kathy Witmer, MN, ARNP Swedish Cancer Institute Thoracic Surgery - Oncology Dyspnea The word denotes disordered breathing

More information

Malignant Spinal cord Compression. Dr. Thiru Thirukkumaran Palliative Care Services - Northwest Tasmania

Malignant Spinal cord Compression. Dr. Thiru Thirukkumaran Palliative Care Services - Northwest Tasmania Malignant Spinal cord Compression Dr. Thiru Thirukkumaran Palliative Care Services - Northwest Tasmania Background Statistics of SCC -1 Incidence of SCC Vertebral body metastases 85 % Para-vertebral (Lymphoma)

More information

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma. Case Scenario 1 An 89 year old male patient presented with a progressive cough for approximately six weeks for which he received approximately three rounds of antibiotic therapy without response. A chest

More information

Common things are common, but not always the answer

Common things are common, but not always the answer Kevin Conroy, Joe Mackenzie, Stephen Cowie kevin.conroy@nhs.net Respiratory Dept, Darlington Memorial Hospital, Darlington, UK. Common things are common, but not always the answer Case report Cite as:

More information

Detection of paraneoplastic anti- neuronal antibodies

Detection of paraneoplastic anti- neuronal antibodies Detection of paraneoplastic anti- neuronal antibodies Dr. A. R. Karim Department of Neuroimmunology University of Birmingham, UK Presentation format Background Detection method Examples Conclusion These

More information

Lung Cancer Resection

Lung Cancer Resection Lung Cancer Resection Introduction The occurrence of lung cancer has increased dramatically over the last 50 years. Your health care provider may have recommended an operation to remove your lung cancer.

More information

HIGH LEVEL - Science

HIGH LEVEL - Science Learning Outcomes HIGH LEVEL - Science Describe the structure and function of the back and spine (8a) Outline the functional anatomy and physiology of the spinal cord and peripheral nerves (8a) Describe

More information

Lung Cancer in Older Adults.. 2 Cases

Lung Cancer in Older Adults.. 2 Cases Lung Cancer in Older Adults.. 2 Cases Cancer in the Older Person Individualised management + Dr Christopher Steer Border Medical Oncology Albury-Wodonga Inaugural Chair Geriatric Oncology Interest Group

More information

Frequently Asked Questions about Cancer Associated Thrombosis

Frequently Asked Questions about Cancer Associated Thrombosis + Frequently Asked Questions about Cancer Associated Thrombosis Atlantic Canada Oncology Group Annual Meeting June 13 th, 2015 Sudeep Shivakumar, Dalhousie University + Conflict of Interest Disclosures

More information

Larry Tan, MD Thoracic Surgery, HSC. Community Cancer Care Educational Conference October 27, 2017

Larry Tan, MD Thoracic Surgery, HSC. Community Cancer Care Educational Conference October 27, 2017 Larry Tan, MD Thoracic Surgery, HSC Community Cancer Care Educational Conference October 27, 2017 To describe patient referral & triage for the patient with suspected lung cancer To describe the initial

More information

VTE General Background

VTE General Background VTE General Background VTE incidence is about 1:1000 persons annually >250,000 admissions for VTE annually >100,000 people die of PE annually >90% of PE s arise from lower limb DVT 50% of DVT at diagnosis

More information

Management of Cancer Associated Thrombosis (CAT) where data is lacking. Tim Nokes Haematologist, Derriford Hospital, Plymouth

Management of Cancer Associated Thrombosis (CAT) where data is lacking. Tim Nokes Haematologist, Derriford Hospital, Plymouth Management of Cancer Associated Thrombosis (CAT) where data is lacking Tim Nokes Haematologist, Derriford Hospital, Plymouth Contents Overview of the statistics and aetiology for Cancer Associated Thrombosis

More information

A 50-year-old woman with syncope

A 50-year-old woman with syncope Hira Shahzad 1, Ali Bin Sarwar Zubairi 2 1 Medical College, Aga Khan University Hospital, Karachi 2 Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan Ali Bin Sarwar Zubairi Associate

More information

Small Cell Lung Cancer Early Detection, Diagnosis, and Staging

Small Cell Lung Cancer Early Detection, Diagnosis, and Staging Small Cell Lung Cancer Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that

More information

Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012

Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012 Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012 INTRODUCTION PNEUMOTHORAX HEMOPTYSIS RESPIRATORY FAILURE Cystic Fibrosis Autosomal Recessive Genetically

More information

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Version 5.2 Version: 5.2 Authorised by: Joint Medicines

More information

BC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine

BC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine BC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine Protocol Code Tumour Group Contact Physician UGOOVBEVV Gynecologic Oncology Dr.

More information

How can we facilitate cross-boundary working in Greater Manchester?

How can we facilitate cross-boundary working in Greater Manchester? How can we facilitate cross-boundary working in Greater Manchester? Emma Halkyard Nurse Clinician Cross boundary working: where are we now? Our patients are complex Our pathways are complex Our treatments

More information

Salisbury Foundation Trust Radiology Department Referral Guidelines for Primary Care: Musculoskeletal Imaging

Salisbury Foundation Trust Radiology Department Referral Guidelines for Primary Care: Musculoskeletal Imaging Salisbury Foundation Trust Radiology Department Referral Guidelines for Primary Care: Musculoskeletal Imaging These guidelines have been issued in conjunction with the Royal College of Radiology referral

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy

More information

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers Dr Ian Chau Consultant Medical Oncologist Women's cancers Breast cancer introduction 3 What profession are you in?

More information

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation

More information